Bharati R Dhruva
Examiner (ID: 3913)
Most Active Art Unit | 1632 |
Art Unit(s) | 1632 |
Total Applications | 2 |
Issued Applications | 1 |
Pending Applications | 1 |
Abandoned Applications | 0 |
Applications
Application number | Title of the application | Filing Date | Status |
---|---|---|---|
Array
(
[id] => 8265973
[patent_doc_number] => 20120165400
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-06-28
[patent_title] => 'GENE REPAIR INVOLVING IN VIVO EXCISION OF TARGETING DNA'
[patent_app_type] => utility
[patent_app_number] => 13/101463
[patent_app_country] => US
[patent_app_date] => 2011-05-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 9972
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13101463
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/101463 | GENE REPAIR INVOLVING IN VIVO EXCISION OF TARGETING DNA | May 4, 2011 | Abandoned |
Array
(
[id] => 8964564
[patent_doc_number] => 20130204166
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-08-08
[patent_title] => 'CUSTOM DESIGNED MICROBUBBLE CONTRAST AGENTS AND TECHNIQUES OF ULTRASOUND DELIVERY OPTIMIZED FOR GENE THERAPY'
[patent_app_type] => utility
[patent_app_number] => 13/640954
[patent_app_country] => US
[patent_app_date] => 2011-04-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 23
[patent_figures_cnt] => 23
[patent_no_of_words] => 23077
[patent_no_of_claims] => 45
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13640954
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/640954 | Custom designed microbubble contrast agents and techniques of ultrasound delivery optimized for gene therapy | Apr 14, 2011 | Issued |
Array
(
[id] => 8812095
[patent_doc_number] => 20130113140
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-05-09
[patent_title] => 'CELL PORATION'
[patent_app_type] => utility
[patent_app_number] => 13/639296
[patent_app_country] => US
[patent_app_date] => 2011-04-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 4146
[patent_no_of_claims] => 29
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13639296
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/639296 | Cell poration | Apr 10, 2011 | Issued |
Array
(
[id] => 8822301
[patent_doc_number] => 20130123346
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-05-16
[patent_title] => 'SYNTHETIC CONSTRUCTS FOR POLYNUCLEOTIDE & PROTEIN EXPRESSION'
[patent_app_type] => utility
[patent_app_number] => 13/261451
[patent_app_country] => US
[patent_app_date] => 2011-04-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 6936
[patent_no_of_claims] => 37
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13261451
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/261451 | SYNTHETIC CONSTRUCTS FOR POLYNUCLEOTIDE & PROTEIN EXPRESSION | Apr 7, 2011 | Abandoned |
Array
(
[id] => 7791018
[patent_doc_number] => 20120052574
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-03-01
[patent_title] => 'NOVEL REAGENTS FOR TRANSFECTION OF EUKARYOTIC CELLS'
[patent_app_type] => utility
[patent_app_number] => 13/073972
[patent_app_country] => US
[patent_app_date] => 2011-03-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 27010
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 15
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0052/20120052574.pdf
[firstpage_image] =>[orig_patent_app_number] => 13073972
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/073972 | Lipids for transfection of Eukaryotic cells | Mar 27, 2011 | Issued |
Array
(
[id] => 8767530
[patent_doc_number] => 20130095567
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-04-18
[patent_title] => 'DIRECTED DIFFERENTIATION AND MATURATION OF PLURIPOTENT CELLS INTO HEPATOCYTE LIKE CELLS BY MODULATION OF WNT-SIGNALLING PATHWAY'
[patent_app_type] => utility
[patent_app_number] => 13/636543
[patent_app_country] => US
[patent_app_date] => 2011-03-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 51
[patent_figures_cnt] => 51
[patent_no_of_words] => 12648
[patent_no_of_claims] => 48
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13636543
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/636543 | Directed differentiation and maturation of pluripotent cells into hepatocyte like cells by modulation of Wnt-signalling pathway | Mar 21, 2011 | Issued |
Array
(
[id] => 6046488
[patent_doc_number] => 20110206611
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-08-25
[patent_title] => 'DNA Dendrimers as Thermal Ablation Devices'
[patent_app_type] => utility
[patent_app_number] => 13/033074
[patent_app_country] => US
[patent_app_date] => 2011-02-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 8072
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0206/20110206611.pdf
[firstpage_image] =>[orig_patent_app_number] => 13033074
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/033074 | DNA Dendrimers as Thermal Ablation Devices | Feb 22, 2011 | Abandoned |
Array
(
[id] => 7571019
[patent_doc_number] => 20110266675
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-11-03
[patent_title] => 'DIRECTIONAL SELF-ASSEMBLY OF BIOLOGICAL ELECTRICAL INTERCONNECTS'
[patent_app_type] => utility
[patent_app_number] => 12/984527
[patent_app_country] => US
[patent_app_date] => 2011-01-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 17468
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 12
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0266/20110266675.pdf
[firstpage_image] =>[orig_patent_app_number] => 12984527
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/984527 | DIRECTIONAL SELF-ASSEMBLY OF BIOLOGICAL ELECTRICAL INTERCONNECTS | Jan 3, 2011 | Abandoned |
Array
(
[id] => 6038886
[patent_doc_number] => 20110091935
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-04-21
[patent_title] => 'PRODUCTION OF RECOMBINANT PROTEINS IN SYNTHETIC MEDIUM'
[patent_app_type] => utility
[patent_app_number] => 12/975788
[patent_app_country] => US
[patent_app_date] => 2010-12-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 3238
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0091/20110091935.pdf
[firstpage_image] =>[orig_patent_app_number] => 12975788
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/975788 | PRODUCTION OF RECOMBINANT PROTEINS IN SYNTHETIC MEDIUM | Dec 21, 2010 | Abandoned |
Array
(
[id] => 6102189
[patent_doc_number] => 20110165682
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-07-07
[patent_title] => 'Human Trophoblast Stem Cells and Use Thereof'
[patent_app_type] => utility
[patent_app_number] => 12/972237
[patent_app_country] => US
[patent_app_date] => 2010-12-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 14
[patent_no_of_words] => 12441
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0165/20110165682.pdf
[firstpage_image] =>[orig_patent_app_number] => 12972237
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/972237 | Human trophoblast stem cells and use thereof | Dec 16, 2010 | Issued |
Array
(
[id] => 7754537
[patent_doc_number] => 20120027725
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-02-02
[patent_title] => 'SAFE LENTIVIRAL VECTORS FOR TARGETED DELIVERY OF MULTIPLE THERAPEUTIC MOLECULES TO TREAT LIVER CANCER'
[patent_app_type] => utility
[patent_app_number] => 12/957178
[patent_app_country] => US
[patent_app_date] => 2010-11-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 52
[patent_figures_cnt] => 52
[patent_no_of_words] => 23607
[patent_no_of_claims] => 31
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0027/20120027725.pdf
[firstpage_image] =>[orig_patent_app_number] => 12957178
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/957178 | SAFE LENTIVIRAL VECTORS FOR TARGETED DELIVERY OF MULTIPLE THERAPEUTIC MOLECULES TO TREAT LIVER CANCER | Nov 29, 2010 | Abandoned |
Array
(
[id] => 8484211
[patent_doc_number] => 20120283618
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-11-08
[patent_title] => 'Method of Inducing Cellular Growth and Materials for Use Therewith'
[patent_app_type] => utility
[patent_app_number] => 13/512321
[patent_app_country] => US
[patent_app_date] => 2010-11-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 13982
[patent_no_of_claims] => 33
[patent_no_of_ind_claims] => 10
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13512321
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/512321 | Method of inducing cellular growth and materials for use therewith | Nov 25, 2010 | Issued |
Array
(
[id] => 8994512
[patent_doc_number] => 08518393
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2013-08-27
[patent_title] => 'Fungi transformant for melanin production and uses thereof'
[patent_app_type] => utility
[patent_app_number] => 12/954768
[patent_app_country] => US
[patent_app_date] => 2010-11-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 19
[patent_figures_cnt] => 32
[patent_no_of_words] => 8301
[patent_no_of_claims] => 1
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 52
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12954768
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/954768 | Fungi transformant for melanin production and uses thereof | Nov 25, 2010 | Issued |
Array
(
[id] => 8370342
[patent_doc_number] => 20120219728
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-08-30
[patent_title] => 'METHODS OF SURFACE TREATING POROUS PARTICLES'
[patent_app_type] => utility
[patent_app_number] => 13/504984
[patent_app_country] => US
[patent_app_date] => 2010-11-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 23232
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13504984
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/504984 | Methods of surface treating porous particles | Nov 22, 2010 | Issued |
Array
(
[id] => 11783922
[patent_doc_number] => 09393194
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2016-07-19
[patent_title] => 'Biocarrier and method of using the same'
[patent_app_type] => utility
[patent_app_number] => 12/953110
[patent_app_country] => US
[patent_app_date] => 2010-11-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 17
[patent_figures_cnt] => 17
[patent_no_of_words] => 4776
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 53
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12953110
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/953110 | Biocarrier and method of using the same | Nov 22, 2010 | Issued |
Array
(
[id] => 8830108
[patent_doc_number] => 20130131153
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-05-23
[patent_title] => 'CULLIN 5 AS A REGULATOR OF HSP90 CLIENTS: A NEW TARGET FOR DRUG DEVELOPMENT'
[patent_app_type] => utility
[patent_app_number] => 13/510093
[patent_app_country] => US
[patent_app_date] => 2010-11-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 8561
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13510093
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/510093 | CULLIN 5 AS A REGULATOR OF HSP90 CLIENTS: A NEW TARGET FOR DRUG DEVELOPMENT | Nov 15, 2010 | Abandoned |
Array
(
[id] => 5943638
[patent_doc_number] => 20110104258
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-05-05
[patent_title] => 'TECHNIQUE FOR DRUG AND GENE DELIVERY TO THE CELL CYTOSOL'
[patent_app_type] => utility
[patent_app_number] => 12/940047
[patent_app_country] => US
[patent_app_date] => 2010-11-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 13732
[patent_no_of_claims] => 31
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0104/20110104258.pdf
[firstpage_image] =>[orig_patent_app_number] => 12940047
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/940047 | Technique for drug and gene delivery to the cell cytosol | Nov 4, 2010 | Issued |
Array
(
[id] => 9850229
[patent_doc_number] => 08951957
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2015-02-10
[patent_title] => 'Delivery agent'
[patent_app_type] => utility
[patent_app_number] => 12/901840
[patent_app_country] => US
[patent_app_date] => 2010-10-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 4483
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 17
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12901840
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/901840 | Delivery agent | Oct 10, 2010 | Issued |
Array
(
[id] => 6054656
[patent_doc_number] => 20110111016
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-05-12
[patent_title] => 'NON-DNA BASE-CONTAINING POLYNUCLEOTIDE COMPOSITIONS AND THEIR USE FOR THE MODULATION OF IMMUNE RESPONSES'
[patent_app_type] => utility
[patent_app_number] => 12/900674
[patent_app_country] => US
[patent_app_date] => 2010-10-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18474
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0111/20110111016.pdf
[firstpage_image] =>[orig_patent_app_number] => 12900674
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/900674 | NON-DNA BASE-CONTAINING POLYNUCLEOTIDE COMPOSITIONS AND THEIR USE FOR THE MODULATION OF IMMUNE RESPONSES | Oct 7, 2010 | Abandoned |
Array
(
[id] => 6126382
[patent_doc_number] => 20110078804
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-03-31
[patent_title] => 'Angiogenin and Amyotrophic Lateral Sclerosis'
[patent_app_type] => utility
[patent_app_number] => 12/897827
[patent_app_country] => US
[patent_app_date] => 2010-10-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 21
[patent_figures_cnt] => 21
[patent_no_of_words] => 29822
[patent_no_of_claims] => 46
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0078/20110078804.pdf
[firstpage_image] =>[orig_patent_app_number] => 12897827
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/897827 | Angiogenin and Amyotrophic Lateral Sclerosis | Oct 4, 2010 | Abandoned |